These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32742321)

  • 21. 14-3-3η protein: a promising biomarker for rheumatoid arthritis.
    Zeng T; Tan L
    Biomark Med; 2018 Aug; 12(8):917-925. PubMed ID: 30022679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity.
    Schwedler C; Häupl T; Kalus U; Blanchard V; Burmester GR; Poddubnyy D; Hoppe B
    Arthritis Res Ther; 2018 Mar; 20(1):44. PubMed ID: 29540200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decrease in 14-3-3η protein levels is correlated with improvement in disease activity in patients with rheumatoid arthritis treated with Tofacitinib.
    Shovman O; Gilburd B; Watad A; Amital H; Langevitz P; Bragazzi NL; Adawi M; Perez D; Lidar M; Katz I; Blank M; Biln NK; Marotta A; Shoenfeld Y
    Pharmacol Res; 2019 Mar; 141():623-626. PubMed ID: 30414892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum 14-3-3η is a Marker that Complements Current Biomarkers for the Diagnosis of RA: Evidence from a Meta-analysis.
    Wu Y; Dai Z; Wang H; Wang H; Wu L; Ling H; Zhu Y; Ye D; Wang B
    Immunol Invest; 2022 Jan; 51(1):182-198. PubMed ID: 32967487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum levels of 14-3-3η protein supplement C-reactive protein and rheumatoid arthritis-associated antibodies to predict clinical and radiographic outcomes in a prospective cohort of patients with recent-onset inflammatory polyarthritis.
    Carrier N; Marotta A; de Brum-Fernandes AJ; Liang P; Masetto A; Ménard HA; Maksymowych WP; Boire G
    Arthritis Res Ther; 2016 Feb; 18():37. PubMed ID: 26832367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rheumatoid Arthritis Patients With Circulating Extracellular Vesicles Positive for IgM Rheumatoid Factor Have Higher Disease Activity.
    Arntz OJ; Pieters BCH; Thurlings RM; Wenink MH; van Lent PLEM; Koenders MI; van den Hoogen FHJ; van der Kraan PM; van de Loo FAJ
    Front Immunol; 2018; 9():2388. PubMed ID: 30420853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive.
    Hiwa R; Ohmura K; Nakabo S; Terao C; Murakami K; Nakashima R; Imura Y; Yukawa N; Yoshifuji H; Hashimoto M; Furu M; Ito H; Fujii T; Mimori T
    Int J Rheum Dis; 2017 Jun; 20(6):731-736. PubMed ID: 28198158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased serum amyloid A and its association with autoantibodies, acute phase reactants and disease activity in patients with rheumatoid arthritis.
    Shen C; Sun XG; Liu N; Mu Y; Hong CC; Wei W; Zheng F
    Mol Med Rep; 2015 Feb; 11(2):1528-34. PubMed ID: 25352049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated serum rheumatoid factor, anti-citrullinated protein antibodies and active rheumatoid arthritis disease are not associated with chronic periodontitis.
    Che Rahim MJ; Wan Mohamad WM; Saddki N; Taib H; Wan Abhamid WZ; Wong KK; Wan Ghazali WS
    Malays J Pathol; 2019 Dec; 41(3):267-272. PubMed ID: 31901911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Significance of v-raf murine sarcoma viral oncogene homologue B1 in rheumatoid arthritis].
    Jin YJ; Sun L; Yang L; Xing R; Liu XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):947-950. PubMed ID: 27987495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Will 14-3-3
    Alashkar DS; Elkhouly RM; Abd Elnaby AY; Nada DW
    Autoimmune Dis; 2022; 2022():1497748. PubMed ID: 35028161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Judging disease activity in rheumatoid arthritis by serum free kappa and lambda light chain levels.
    Ye Y; Li SL; Xie M; Jiang P; Liu KG; Li YJ
    Kaohsiung J Med Sci; 2013 Oct; 29(10):547-53. PubMed ID: 24099109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association of serum RANKL levels with disease activity and hematological parameters in Syrian patients with rheumatoid arthritis.
    Hussein R; Aboukhamis I
    Biochem Biophys Rep; 2022 Dec; 32():101373. PubMed ID: 36304516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis.
    Yang X; Lin K; Ni S; Wang J; Tian Q; Chen H; Brown MA; Zheng K; Zhai W; Sun L; Jin S; Wang J
    Arthritis Res Ther; 2017 Nov; 19(1):257. PubMed ID: 29166915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevation of serum matrix metalloproteinase-3 as a predictive marker for the long-term disability of rheumatoid arthritis patients in a prospective observational cohort IORRA.
    Shinozaki M; Inoue E; Nakajima A; Hara M; Tomatsu T; Kamatani N; Yamanaka H
    Mod Rheumatol; 2007; 17(5):403-8. PubMed ID: 17929133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR/EULAR classification of rheumatoid arthritis.
    Van Hoovels L; Jacobs J; Vander Cruyssen B; Van den Bremt S; Verschueren P; Bossuyt X
    Ann Rheum Dis; 2018 May; 77(5):667-677. PubMed ID: 29363510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: evaluation of clinical value and association with disease activity.
    Shakiba Y; Koopah S; Jamshidi AR; Amirzargar AA; Massoud A; Kiani A; Nicknam MH; Nazari B; Nikbin B
    Iran J Allergy Asthma Immunol; 2014 Jun; 13(3):147-56. PubMed ID: 24659118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of detecting HLA-DR, 14-3-3η protein and d-dimer in the diagnosis of rheumatoid arthritis.
    Tan L; Wang Q; Zeng T; Long T; Guan X; Wu S; Zheng W; Fu H; Meng Y; Wu Y; Tian Y; Yu J; Chen J; Li H; Cao L
    Biomark Med; 2018 Jul; 12(7):697-705. PubMed ID: 29856230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.